Atlas Trials

A Trial of Paclitaxel (Albumin-binding) for Castration-resistant Prostate Cancer

Clinical trial NCT04148885 · UNKNOWN

Trial details

NCT number
NCT04148885
Sponsor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Castration-resistant Prostate Cancer
Start date
2019-11-01
Primary completion
2020-07-01
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.